所属公司:瑞典Neuro Vive制药有限公司
公司职位:首席执行官
所在地区:其他
创业领域:生物医疗
Mikael Bronnegard, chief executive officer of NeuroVive, also welcomed the agreement, describing it as "strong validation of the huge potential of mitochondrial medicine".